- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT04652856
Neurocognitive Basis of Attention and Eye Movement Guidance in the Real World Scenes
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Description détaillée
The ability to conduct a visual search for an object in a naturalistic scene is a crucial component of everyday interactions with the environment. This process requires the recognition of different items, accessing stored semantic knowledge about those items and their relationships with other objects, and guiding vision based on that knowledge. Classical models of attention emphasize low-level visual salience maps for attentional guidance. However, behavioral studies increasingly support a role for object knowledge in guiding attention and eye movements. Despite strong behavioral evidence that conceptual information about objects and scenes is critical for real world guidance of attention, very little is known about the neural basis of the guidance of attention based on meaning.
Previous human imaging studies have identified several brain regions that represent object and scene/context knowledge as it relates to visual recognition. In particular, regions of the temporal lobes (inferior temporal regions (ITC), parahippocampal cortex (PHC), and the hippocampus) are critical for perceiving and understanding objects, but little is known about the role of these individual regions in how they interact to guide attention and eye movements in real-world scenes.
Electrical brain stimulation is routinely performed clinically in the surgical treatment of epilepsy patients, both intraoperatively and using implanted electrodes. It is used as standard of care both to map eloquent brain function prior to surgical treatment for epilepsy and to map the seizure network. The purpose of this study is to gain a better understanding of the information flow and neural dynamics of the brain, examining the impact of electrical brain stimulation on stimulus search time, accuracy, and eye movement trajectories.
Type d'étude
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Pennsylvania
-
Pittsburgh, Pennsylvania, États-Unis, 15213
- UPMC Presbyterian
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Have intracranial EEG electrodes implanted for stage II epilepsy planning.
- Have adequate cognitive and communication ability to give informed consent, understand instructions, and follow direction.
- Be able to understand the tasks and provide responses.
- IQ > 75 (done as part of standard-of-care neuropsychological testing as part of the surgical treatment for epilepsy)
- Speak English
Exclusion Criteria:
- Inability to understand or perform the tasks outlined in this protocol
- In excessive postoperative discomfort.
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Science basique
- Répartition: N / A
- Modèle interventionnel: Affectation à un seul groupe
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Electrical and Sham Electrical Brain Stimulation
Electrical brain stimulation and sham electrical brain stimulation will be administered to all participants.
|
Electrical Brain Stimulation (EBS) will be used to disrupt local neural activity in inferior temporal regions (ITC), parahippocampal cortex (PHC), the hippocampus, and control regions.
The effects of EBS will be examined on attention and eye movement behavior, and all participants will receive both EBS and sham electrical brain stimulation.
Sham electrical brain stimulation (SEBS) will be applied to inferior temporal regions (ITC), parahippocampal cortex (PHC), the hippocampus, and control regions.
The effects of SEBS will be examined on attention and eye movement behavior, and all participants will receive both SEBS and EBS.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Incidence of eye fixations during electrical brain stimulation (EBS) vs. sham electrical brain stimulation (SEBS).
Délai: Eye fixation incidence will be assessed during the intervention, through study completion, up to 1 week on average.
|
Eye fixations will be assessed using an eye tracking device, which collects videos of eye movements.
Participants will be presented with an image of a scene, and asked to locate a target object.
The incidence of eye fixations occurring before participants locate the target object will be measured at preferred and control brain regions during EBS and SEBS.
|
Eye fixation incidence will be assessed during the intervention, through study completion, up to 1 week on average.
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Search time for target object during EBS vs. SEBS.
Délai: Search Time will be assessed during the intervention, through study completion, up to 1 week on average.
|
Visual search time will be assessed by asking participants to answer a simple question about a target object in an image of a scene as quickly and accurately as possible.
The question will presented to the participants, followed by the image of the scene.
The search time to locate the target object and respond to the question will be measured at preferred and control brain regions during EBS and SEBS.
|
Search Time will be assessed during the intervention, through study completion, up to 1 week on average.
|
|
Identification accuracy during EBS vs. SEBS.
Délai: Identification accuracy will be assessed during the intervention, through study completion, up to 1 week on average.
|
Identification accuracy rate will be assessed based on the participants' correct responses for identifying a target object in an image of a scene (described in Outcomes 1 and 2).
The search time to locate the target object will be measured at preferred and control brain regions during EBS and SEBS.
|
Identification accuracy will be assessed during the intervention, through study completion, up to 1 week on average.
|
Collaborateurs et enquêteurs
Parrainer
Collaborateurs
Les enquêteurs
- Chercheur principal: Avniel S Ghuman, PhD, University of Pittsburgh
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude (Anticipé)
Achèvement primaire (Anticipé)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Réel)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Mots clés
Autres numéros d'identification d'étude
- STUDY19090010
- 1R21EY030297-01A1 (Subvention/contrat des NIH des États-Unis)
Plan pour les données individuelles des participants (IPD)
Prévoyez-vous de partager les données individuelles des participants (DPI) ?
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Étudie un produit d'appareil réglementé par la FDA américaine
produit fabriqué et exporté des États-Unis.
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .